B. W. Mccrindle, Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association, Circulation, vol.135, pp.927-999, 2017.

A. Dionne and N. Dahdah, Myocarditis and Kawasaki disease, Int. J. rheumatic Dis, vol.21, pp.45-49, 2017.

C. Tissandier, Kawasaki shock syndrome complicating a recurrence of Kawasaki disease, Pediatrics, vol.134, pp.1695-1699, 2014.

W. Wang, F. Gong, W. Zhu, S. Fu, and Q. Zhang, Macrophage activation syndrome in Kawasaki disease: more common than we thought?, Semin. arthritis rheumatism, vol.44, pp.405-410, 2015.

K. Furusho, High-dose intravenous gammaglobulin for Kawasaki disease, Lancet, vol.2, pp.1055-1058, 1984.

M. Terai and S. T. Shulman, Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose, J. pediatrics, vol.131, pp.888-893, 1997.

M. Mori, Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease, Mod. Rheumatol, vol.14, pp.361-366, 2004.

R. M. Tulloh, Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015, Arch. Dis. Child, vol.104, pp.640-646, 2018.

C. A. Wallace, J. W. French, S. J. Kahn, and D. D. Sherry, Initial intravenous gammaglobulin treatment failure in Kawasaki disease, Pediatrics, vol.105, p.78, 2000.

T. Kobayashi, Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial, Lancet, vol.379, pp.1613-1620, 2012.

D. Eleftheriou, Management of Kawasaki disease, Arch. Dis. Child, vol.99, pp.74-83, 2014.

K. Egami, Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease, J. pediatrics, vol.149, pp.237-240, 2006.

T. Sano, Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment, Eur. J. pediatrics, vol.166, pp.131-137, 2007.

T. Kobayashi, Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease, Circulation, vol.113, pp.2606-2612, 2006.

L. A. Sleeper, Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance, J. pediatrics, vol.158, pp.831-835, 2011.

A. H. Tremoulet, Resistance to intravenous immunoglobulin in children with Kawasaki disease, J. pediatrics, vol.153, pp.117-121, 2008.

J. Sanchez-manubens, Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population, Rheumatol. Int, vol.36, pp.905-910, 2016.

S. Davies, Predicting IVIG resistance in UK Kawasaki disease, Arch. Dis. Child, vol.100, pp.366-368, 2015.

E. Fernandez-cooke, Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development, KAWA-RACE study group, vol.14, p.215665, 2011.

R. Song, W. Yao, and X. Li, Efficacy of Four Scoring Systems in Predicting Intravenous Immunoglobulin Resistance in Children with Kawasaki Disease in a Children's Hospital in Beijing, North China. J. pediatrics, vol.184, pp.120-124, 2017.

J. Shin, H. Lee, and L. Eun, Verification of Current Risk Scores for Kawasaki Disease in Korean Children, J. Korean Med. Sci, vol.32, 1991.

M. Bar-meir, Prediction of Resistance to Intravenous Immunoglobulin in Children With Kawasaki Disease, Journal of the Pediatric Infectious Diseases Society, 2017.

T. Kibata, Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin, Int. J. cardiology, vol.214, pp.209-215, 2016.

, Cardiac Surgery Committee for Development of Guidelines for Medical Treatment of Acute Kawasaki, D. Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version), Pediatr. Int, vol.56, pp.135-158, 2014.

J. S. Baek, Coronary artery status of patients with transient fever 24-36 h after first IVIG infusion did not differ from that seen in responsive patients, Pediatr. Rheumatol. Online J, vol.16, p.83, 2018.

, Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease, Ministry of Health and Welfare, 1994.

M. Seki, External validation of a risk score to predict intravenous immunoglobulin resistance in patients with kawasaki disease, Pediatric Infect. Dis. J, vol.30, pp.145-147, 2011.

T. Heuclin, Increased detection rate of Kawasaki disease using new diagnostic algorithm, including early use of echocardiography, J. pediatrics, vol.155, p.691, 2009.

S. Bayers, S. T. Shulman, and A. S. Paller, Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis, J. Am. Acad. Dermatol, vol.69, issue.501, pp.501-511, 2013.

M. C. Maggio, G. Corsello, E. Prinzi, and R. Cimaz, Kawasaki disease in Sicily: clinical description and markers of disease severity, Ital. J. Pediatr, vol.42, p.92, 2016.

J. Saundankar, The epidemiology and clinical features of Kawasaki disease in Australia, Pediatrics, vol.133, pp.1009-1014, 2014.

J. W. Newburger, The treatment of Kawasaki syndrome with intravenous gamma globulin, N. Engl. J. Med, vol.315, pp.341-347, 1986.

D. Chbeir, Kawasaki disease: abnormal initial echocardiogram is associated with resistance to IV Ig and development of coronary artery lesions, Pediatr. Rheumatol. Online J, vol.16, p.48, 2018.

A. R. Porcalla, C. A. Sable, K. M. Patel, G. R. Martin, and N. Singh, The epidemiology of Kawasaki disease in an urban hospital: does African American race protect against coronary artery aneurysms?, Pediatr. Cardiol, vol.26, pp.775-781, 2005.

D. E. Clark, Predictors of Intravenous Immunoglobulin Nonresponse and Racial Disparities in Kawasaki Disease, Pediatric Infect. Dis. J, vol.37, pp.1227-1234, 2018.

D. Rigante, Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome, Int. J. Mol. Sci, vol.17, p.278, 2016.

S. Ogata, Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial, Pediatrics, vol.129, pp.17-23, 2012.

E. Berdej-szczot, Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease, Kardiol. Pol, vol.75, pp.261-266, 2017.

T. Xie, Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease, Pediatr. Rheumatol. Online J, vol.15, p.17, 2017.

Y. Wu, Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm, Clin. Exp. Med, vol.19, pp.173-181, 2019.

M. B. Son, Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores, J. Am. Heart Assoc, vol.6, p.6, 2017.